CVSStock
Verdicts genuinely change. Free email alert the moment CVS's does — no target price to set, unlike a price alert.
Stable Ratio screen, 3 of 7 decided standards passing. No standard's deciding ratio sits within 3 points of its line. What would change it
Whether this company clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
Trade setup
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
Why this signal?
The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.
CVS is currently considered not halal (non-compliant), per our in-house ratio engine. See the full ratio breakdown and business-activity screen below for the reasoning.
⚠️ Financial ratios are only half the screen. A company whose core business is in an excluded sector — weapons/defense, alcohol, gambling, conventional (interest-based) finance, tobacco, pork, or adult entertainment — is non-compliant even if every debt and income ratio passes. So passing ratios below don't override this verdict; check the business-activity screen for the reason.
433 other Healthcare stocks pass this same screen. See compliant Healthcare stocks →
How the status reached this point
Non-compliant · status tracked since Nov 17, 2026
No change to CVS’s published status has been recorded since our daily status check began on Nov 17, 2026. What it read before then is not on record here.
Read once a day from our own screen, last on Nov 18, 2026. The per-methodology record is under “What changed, and when” in the in-house research.
🕌 In-house Compliance Research
Computed from published company financials, balance sheet as of 2026-09-30. These ratios come from the issuer's own published statements rather than structured SEC data.
AAOIFI divides by the market cap: $113.3B as of 2026-11-17. At the 2026-11-19 close it is about $104.2B (the stored market cap moved by the share price since, not a new share count), and at that cap AAOIFI's interest-bearing debt ratio would read 72.3% (66.4% at the stored cap, against a 30% line) and interest-bearing investments ratio would read 14.5% (13.3% at the stored cap, against a 30% line). The published verdict changes only when the company is re-screened.
Business activity: cleared (no excluded categories detected)
AAOIFI Fail 2 of 3 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 66.43% | 30.00% | Fail(36.4pp over) |
| Interest-bearing investments | 13.32% | 30.00% | Pass(16.7pp buffer) |
| Non-permissible income | 0.57% | 5.00% | Pass(4.4pp buffer) |
Usmani Pass 4 of 4 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 29.18% | 33.00% | Pass(3.8pp buffer) |
| Interest-bearing investments | 5.85% | 33.00% | Pass(27.2pp buffer) |
| Non-liquid assets | 77.85% | at least 20.00% | Pass(57.8pp above the floor) |
| Non-permissible income | 0.57% | 5.00% | Pass(4.4pp buffer) |
MSCI Pass 4 of 4 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 29.18% | 33.33% | Pass(4.2pp buffer) |
| Cash + interest-bearing securities | 5.85% | 33.33% | Pass(27.5pp buffer) |
| Accounts receivable | 22.15% | 33.33% | Pass(11.2pp buffer) |
| Non-permissible income | 0.57% | 5.00% | Pass(4.4pp buffer) |
FTSE Pass 4 of 4 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 23.51% | 33.33% | Pass(9.8pp buffer) |
| Cash + interest-bearing securities | 5.85% | 33.33% | Pass(27.5pp buffer) |
| Accounts receivable | 22.15% | 50.00% | Pass(27.8pp buffer) |
| Non-permissible income | 0.57% | 5.00% | Pass(4.4pp buffer) |
Dow Jones Islamic Market Fail 2 of 4 ratios pass
Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 72.10% | 33.00% | Fail(39.1pp over) |
| Cash + interest-bearing securities | 14.46% | 33.00% | Pass(18.5pp buffer) |
| Accounts receivable | 40.29% | 33.00% | Fail(7.3pp over) |
| Non-permissible income | 0.57% | 5.00% | Pass(4.4pp buffer) |
S&P Shariah Fail 3 of 4 ratios pass
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 77.25% | 33.00% | Fail(44.3pp over) |
| Cash + interest-bearing securities | 15.49% | 49.00% | Pass(33.5pp buffer) |
| Accounts receivable | 43.16% | 49.00% | Pass(5.8pp buffer) |
| Non-permissible income | 0.57% | 5.00% | Pass(4.4pp buffer) |
MSCI M-Series Fail 2 of 4 ratios pass
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 77.25% | 33.33% | Fail(43.9pp over) |
| Cash + interest-bearing securities | 15.49% | 33.33% | Pass(17.8pp buffer) |
| Accounts receivable | 58.65% | 49.00% | Fail(9.7pp over) |
| Non-permissible income | 0.57% | 5.00% | Pass(4.4pp buffer) |
Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.
How close is it to flipping?
Every current reading against its own line, closest first. A verdict is only as durable as that distance.
The numbers the ratios are built from
Read from CVS's own filings. Every percentage on this page is one of these lines divided by another, so the inputs are shown rather than asserted.
| Line | Figure | As reported | Read from |
|---|---|---|---|
| RevenueTotal revenue for the period | $402.1B | 2025-12-31 | Revenues |
| Interest-bearing debtShort and long-term borrowings | $60.7B | 2026-09-30 | LongTermDebtAndCapitalLeaseObligations, LongTermDebtAndCapitalLeaseObligationsCurrent |
| Cash and interest-bearing securitiesCash, equivalents and marketable securities | $15.1B | 2026-09-30 | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents, ShortTermInvestments |
| Total assetsBalance sheet total | $258.1B | 2026-09-30 | Assets |
| Market capDenominator for AAOIFI | $113.3B | live quote | price x shares |
| 36-month average market capDenominator for S&P Shariah and MSCI M-Series | $87.7B | 756 trading days | closes x shares |
| 24-month average market capDenominator for Dow Jones Islamic Market | $93.7B | 504 trading days | closes x shares |
| Non-permissible revenueInterest and excluded income | $2.2B | 2025-12-31 | NetInvestmentIncome |
Two dates, not one: a balance-sheet line and an income-statement line cover different windows by design, so each figure carries its own.
Sources
Filing information. Balance sheet as of 2026-09-30. Income statement as of 2025-12-31. Screened 2026-11-17.
Filing links appear after the next screen: this row was screened before filing citations were recorded.
-
Total assets$258.1B
Assets· balance sheet as of 2026-09-30 -
Interest-bearing debt$60.7B
LongTermDebtAndCapitalLeaseObligations, LongTermDebtAndCapitalLeaseObligationsCurrent· balance sheet as of 2026-09-30 -
Cash and interest-bearing securities$15.1B
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents, ShortTermInvestments· balance sheet as of 2026-09-30 -
Receivables$42.1B
AccountsReceivableNetCurrent· balance sheet as of 2026-09-30 -
Revenue$402.1B
Revenues· income statement as of 2025-12-31 -
Interest income (non-permissible)$2.2B
NetInvestmentIncome· income statement as of 2025-12-31 -
Market cap$113.3BMarket-data quote at screen time, 2026-11-17 · not a filing figure, so no link
What changed, and when
Verdict history for CVS. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.
- 2026-09-07 No change recorded No verdict change for CVS has been recorded since tracking began. The scan ledger records that the compliance detectors ran, not which symbols each pass covered.
Tracked since 2026-09-07.
Revenue by business segment
Not disclosed by segment: the latest 10-K (fiscal year ended 2025-12-31) does not tag its revenue by product, service or business segment in its XBRL, so there is no split to show. None is estimated.
Source: 10-K filed 2026-02-10 (accession 0000064803-26-000010), read from its XBRL on SEC EDGAR.
What would change the status
The headline verdict is the majority of the decided ratio standards — 3 pass and 4 fail of 7 — with a business-activity screen and any hold applied on top. Balance sheet as of 2026-09-30; market cap as stored on 2026-11-17.
No standard's deciding ratio sits within 3 points of its line.
The ratios that move with the share price
AAOIFI's debt ratio is $75.3B debt (operating leases included, as the screen counts it) over a market cap of $113.3B (as of 2026-11-17), 66.4% against a 30% line.
At the 2026-11-19 close the market cap is about $104.2B (the stored cap moved by the share price since), so this ratio would read 72.3%; the line is +141% from there. The published status changes only when the company is re-screened.
It would pass if the market cap rose above $251.0B (+121%), about $196.17 a share against $88.59 implied by the screen's own figures.
AAOIFI would then pass; the majority verdict would stay Not compliant (4 of 7 decided standards passing), because it is held (Zoya rates it not compliant, and our screen does not overrule another screener's doubt).
At the screen's market cap, it would take $41.3B less debt to clear the line.
AAOIFI would then pass; the majority verdict would stay Not compliant (4 of 7 decided standards passing, counting every standard that divides the same figure), because it is held (Zoya rates it not compliant, and our screen does not overrule another screener's doubt).
AAOIFI's investments ratio (13.3% against a 30% line) would only fail if the market cap fell by 56%, to $50.3B. At the 2026-11-19 close it would read 14.5%.
Only AAOIFI divides by the market cap itself. The Dow Jones, S&P and MSCI M-Series standards divide by a 24- or 36-month average and the others by total assets, so a day's price move does not reach them. Figures are the screen's own; the live market cap differs from the stored one.
Shariah-compliant alternatives
Compliant companies in Healthcare Plans listed on the same market, largest first. Each is screened on its own; none carries a documented concern or a hold.
| Company | Market cap | Price, day |
|---|---|---|
| PGNYProgyny Inc | $2.0B | — |
A dash means no fresh quote is cached for that symbol; this list does not fetch one.
Funds that hold CVS
19 of the 229 funds whose filed holdings we currently hold own CVS shares. That set is a fixed list of widely held index funds and Shariah funds, plus the funds our look-through has read most recently. It is not every fund that owns CVS.
You may already own itWidely held U.S. index funds. If you own one, you own CVS through it. None of them is a Shariah fund; the last column is our look-through of each.
| Fund | CVS in fund | Fund compliant by weight |
|---|---|---|
| VYM VANGUARD HIGH DIVIDEND YIELD INDEX FUND | 0.54% | 46% |
| RSP Invesco S&P 500 Equal Weight ETF | 0.21% | 44% |
| SPY | 0.20% | 56% |
| VOO VANGUARD 500 INDEX FUND | 0.20% | 56% |
| SPYM State Street(R) SPDR(R) Portfolio S&P 500(R) ETF | 0.20% | 56% |
| IVV iShares Core S&P 500 ETF | 0.20% | 56% |
| VTI VANGUARD TOTAL STOCK MARKET INDEX FUND | 0.18% | 54% |
| ITOT iShares Core S&P Total U.S. Stock Market ETF | 0.18% | 54% |
| SCHB Schwab U.S. Broad Market ETF | 0.16% | 53% |
| Fund | CVS in fund | Fund compliant by weight |
|---|---|---|
| JGYAX Global Shareholder Yield Fund | 1.68% | 32% |
| DVY iShares Select Dividend ETF | 1.49% | 16% |
| TMED T. Rowe Price Health Care ETF | 1.22% | 60% |
| BIGRX Disciplined Value Fund | 0.90% | 49% |
| ULVM VictoryShares US Value Momentum ETF | 0.80% | 25% |
| FFLV Fidelity Fundamental Large Cap Value ETF | 0.57% | 38% |
| JPUS JPMorgan Diversified Return U.S. Equity ETF | 0.40% | 43% |
| CVLC Calvert US Large-Cap Core Responsible Index ETF | 0.24% | 56% |
| DSPY Tema S&P 500 Historical Weight ETF Strategy | 0.23% | 53% |
| GEQ Cambria Global EW 2 ETF | 0.03% | 37% |
Sorted by CVS’s share of each fund, from the fund’s latest SEC N-PORT filing. “Compliant by weight” is the share of the fund’s holdings our look-through screens compliant. A fund is listed only where its filing is mostly equity and names CVS once, so a bond is not counted as the shares; 1 more fund name CVS in a way we cannot separate from its bonds, and is not listed. Shariah funds are those with a recorded certification, on our halal ETF list, or named Shariah, Islamic, Halal or Sukuk.
| Investor | Firm | Position | Weight | As of |
|---|---|---|---|---|
| Dodge & Cox | Dodge & Cox | $3,945M | 2.1% | 2026-09-30 |
| Christopher Davis | Davis Selected Advisers | $1,019M | 4.4% | 2026-09-30 |
| Richard Pzena | Pzena Investment Management | $882M | 2.6% | 2026-09-30 |
| Ken Griffin | Citadel Advisors | $424M | 0.0% | 2026-09-30 |
| Peter Brown | Renaissance Technologies | $233M | 0.3% | 2026-09-30 |
| Prem Watsa | Fairfax Financial Holdings | $232M | 8.8% | 2026-09-30 |
| Israel Englander | Millennium Management | $188M | 0.1% | 2026-09-30 |
| David Shaw | D. E. Shaw & Co. | $164M | 0.1% | 2026-09-30 |
| Charles Brandes | Brandes Investment Partners | $124M | 0.9% | 2026-09-30 |
| Larry Robbins | Glenview Capital Management | $110M | 1.8% | 2026-09-30 |
| Samantha McLemore | Patient Capital Management | $83M | 2.6% | 2026-09-30 |
| John Rogers | Ariel Investments | $71M | 0.7% | 2026-09-30 |
| Jeremy Grantham | GMO | $47M | 0.1% | 2026-09-30 |
| Joel Greenblatt | Gotham Asset Management | $40M | 0.1% | 2026-09-30 |
| Ray Dalio | Bridgewater Associates | $32M | 0.1% | 2026-09-30 |
| Bill Nygren | Harris Associates (Oakmark) | $22M | 0.0% | 2026-09-30 |
| Steven Cohen | Point72 Asset Management | $21M | 0.0% | 2026-09-30 |
| Jeff Auxier | Auxier Asset Management | $8M | 1.1% | 2026-09-30 |
| Ken Fisher | Fisher Asset Management | $8M | 0.0% | 2026-09-30 |
| Mario Gabelli | GAMCO Investors | $8M | 0.1% | 2026-09-30 |
| Paul Tudor Jones | Tudor Investment Corp | $6M | 0.0% | 2026-09-30 |
| Louis Bacon | Moore Capital Management | $4M | 0.1% | 2026-09-30 |
| John Hussman | Hussman Strategic Advisors | $4M | 0.8% | 2026-09-30 |
| Lee Ainslie | Maverick Capital | $2M | 0.0% | 2026-09-30 |
| Jefferies | Jefferies Financial Group | $1M | 0.0% | 2026-09-30 |
| David Katz | Matrix Asset Advisors | $1M | 0.0% | 2026-09-30 |
| Caxton Associates | Caxton Associates LLP | $0M | 0.0% | 2026-09-30 |
| Sallie Krawcheck | Ellevest | $0M | 0.0% | 2026-09-30 |
From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
Price Forecast
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Technical Summary
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Every indicator, and what it reads
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 35.00 | NEUTRAL |
| Stochastic %K (14) | 18.61 | BUY |
| CCI (20) | -139.90 | BUY |
| Williams %R (14) | -81.39 | BUY |
| MACD (12,26,9) | -0.65 | SELL |
| ROC (10) | -1.59 | SELL |
| Momentum (10) | -1.29 | SELL |
| EMA (10) | 85.41 | SELL |
| SMA (10) | 86.26 | SELL |
| EMA (20) | 86.84 | SELL |
| SMA (20) | 87.57 | SELL |
| EMA (30) | 87.66 | SELL |
| SMA (30) | 88.59 | SELL |
| EMA (50) | 88.97 | SELL |
| SMA (50) | 88.34 | SELL |
| EMA (100) | 90.24 | SELL |
| SMA (100) | 93.87 | SELL |
| EMA (200) | 86.46 | SELL |
| SMA (200) | 88.29 | SELL |
About CVS
Healthcare · Healthcare Plans
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail-order pharmacy, clinical services, disease management, medical spend management services, and pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, CMS, plans offered on public health insurance exchanges, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
Background via Yahoo Finance — informational, not part of the verdict.
Average — needs more confirmation before sizing up
SMC — Top Down
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | BEARISH | 64 |
| ⏰ 4H | BEARISH | 52 |
| 🕐 1H | BEARISH | 98 |
| ⏱ 15-Min | BEARISH | 130 |
| ⏲ 5-Min | RANGING | 234 |
Momentum & Volume
Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.
Peer Movement
How the rest of the sector moved over the same window. Context for a price move, never a cause of one.
Peer movement computing — it will appear here on its own.
Before you act on this
The questions worth asking about any verdict on this page, answered plainly.
Is this a fatwa?
No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.
Why can the standards disagree?
Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.
How often is this re-screened?
Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.
Do I need to purify dividends?
If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Compare with
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Insider Activity (90d)
Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.
NO DATA 0 buys · 0 sells
COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE
The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.
NEUTRAL report date 2026-11-10 · Asset managers net 914130 (-14454)
AI Summary
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.